Pathophysiology of chronic kidney disease-mineral and bone disorder

被引:35
|
作者
Mac Way, Fabrice [1 ,2 ,3 ]
Lessard, Myriam [1 ,2 ,4 ]
Lafage-Proust, Marie-Helene [1 ,2 ]
机构
[1] Univ Lyon, INSERM, U1059, F-42023 St Etienne 2, France
[2] CHU St Etienne, F-42055 St Etienne 2, France
[3] Hotel Dieu Quebec, Nephrol, Quebec City, PQ G1R 2J6, Canada
[4] Hop Sacre Coeur Montreal, Ouest Montreal, PQ H4J 1C5, Canada
关键词
Parathyroid hormone; FGF23; Bone biopsy; Bone turnover; Osteomalacia; Secondary hyperparathyroidism; HYPERPLASTIC PARATHYROID-GLANDS; RENAL OSTEODYSTROPHY; CKD PATIENTS; SECONDARY HYPERPARATHYROIDISM; DEPRESSED EXPRESSION; DOWN-REGULATION; RECEPTOR; CALCIUM; FGF23; PTH;
D O I
10.1016/j.jbspin.2012.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) alters the metabolism of several minerals, thereby inducing bone lesions and vessel-wall calcifications that can cause functional impairments and excess mortality. The histological bone abnormalities seen in CKD, known as renal osteodystrophy, consist of alterations in the bone turnover rate, which may be increased (osteitis fibrosa [OF]) or severely decreased (adynamic bone disease [AD]); abnormal mineralization (osteomalacia [OM]), and bone loss. Secondary hyperparathyroidism is related to early phosphate accumulation (responsible for FGF23 overproduction by bone tissue), decreased calcitriol production by the kidneys, and hypocalcemia. Secondary hyperparathyroidism is associated with OF. Other factors that affect bone include acidosis, chronic inflammation, nutritional deficiencies, and iatrogenic complications. (C) 2012 Published by Elsevier Masson SAS on behalf of the Societe Francaise de Rhumatologie.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [1] Management of Chronic Kidney Disease-Mineral Bone Disorder
    Fadem, Stephen Z.
    Moe, Sharon M.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (01) : 2 - 2
  • [2] Chronic Kidney Disease-Mineral and Bone Disorder in Asia
    Fukagawa, Masafumi
    Komaba, Hirotaka
    KIDNEY DISEASES, 2017, 3 (01) : 1 - 7
  • [3] Calcimimetics in the chronic kidney disease-mineral and bone disorder
    Bover, Jordi
    Aguilar, Armando
    Baas, Juan P.
    Reyes, Joselyne
    Lloret, Maria-J.
    Farre, Neus
    Olaya, Mayte
    Canal, Cristina
    Marco, Helena
    Andres, Enric
    Trinidad, Pedro
    Ballarin, Jose
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (02) : 108 - 121
  • [4] Current therapeutic approach of chronic kidney disease-mineral and bone disorder
    Zaimi, Maria
    Grapsa, Eirini
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (05) : 671 - 689
  • [5] Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder
    Kumar, Juhi
    Furth, Susan L.
    Warady, Bradley A.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2012, 10 (03): : 219 - 234
  • [6] A rat model of chronic kidney disease-mineral bone disorder
    Moe, Sharon M.
    Chen, Neal X.
    Seifert, Mark F.
    Sinders, Rachel M.
    Duan, Dana
    Chen, Xianming
    Liang, Yun
    Radcliff, J. Scott
    White, Kenneth E.
    Gattone, Vincent H., II
    KIDNEY INTERNATIONAL, 2009, 75 (02) : 176 - 184
  • [7] Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder
    Hanudel, Mark R.
    Salusky, Isidro B.
    CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (03) : 198 - 206
  • [8] Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder
    Juhi Kumar
    Susan L. Furth
    Bradley A. Warady
    Clinical Reviews in Bone and Mineral Metabolism, 2012, 10 (3): : 219 - 234
  • [9] Management of Chronic Kidney Disease-Mineral Bone Disorder
    Ruf, Kathryn M.
    Clifford, Timothy
    ORTHOPEDICS, 2010, 33 (02) : 98 - 101
  • [10] Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis
    Salera, Davide
    Merkel, Nathalie
    Bellasi, Antonio
    de Borst, Martin H.
    CLINICAL KIDNEY JOURNAL, 2025, 18 : i3 - i14